Comprehensive geriatric assessment

OneOncology and Practice Partners to Present 11 Abstracts at ASCO Quality Care Symposium

Retrieved on: 
Tuesday, October 17, 2023
DNA sequencing, LPN, MSN, Parent, Workforce, Physician, Comprehensive geriatric assessment, Doctor of Philosophy, Personalized medicine, Abstract, MS, Research, Breast cancer, Economics, Prompt, Palliative care, Community Oncology Alliance, Sibling, Next Generation, Behavior, OCM, DO, FDA, Electronic health record, DNP, Genetic testing, OPN, OCN, Oncology, ASCO, MPT, Occupational therapy, AOCNP, MMHC, The Center, Patient, Quality of life, Vaccine, Pharmaceutical industry, Nursing, Medical imaging, NP-C, MD, Cancer, RN, Germline

NASHVILLE, Tenn., Oct. 17, 2023 /PRNewswire/ -- OneOncology, the national platform for independent oncology practices, announced today that researchers at OneOncology and its partner practices will present 11 abstracts at the upcoming ASCO Quality Care Symposium October 27-28.

Key Points: 
  • Researchers to Present on Genetic Testing, Precision Medicine, Care Delivery & Physician Workforce Research
    NASHVILLE, Tenn., Oct. 17, 2023 /PRNewswire/ -- OneOncology, the national platform for independent oncology practices, announced today that researchers at OneOncology and its partner practices will present 11 abstracts at the upcoming ASCO Quality Care Symposium October 27-28.
  • Neha Jain, Ph.D., OneOncology's Senior Director of Precision Medicine, will present "Provider Messaging for Precision Treatment (ProMPT): A Notification Pilot to Inform Actionable Genomic Findings."
  • The next iteration of ProMPT will use OneOncology's proprietary analytics platform to incorporate genomic information into our physicians' workstream.
  • Tennessee Oncology researchers will present six abstracts addressing topics including clinical innovation, care delivery, OCM learnings and implications for value-based care, automating behavior economics and analytics to improve palliative care, and scaling oncology disease expertise in urban and rural clinics.

City of Hope-led panel of experts updates cancer and aging guidelines issued by the American Society of Clinical Oncology

Retrieved on: 
Monday, July 17, 2023
Cognition, City of Hope, City of Hope National Medical Center, Housing, American Journal of Clinical Oncology, Hospital, Senior counsel, American Society of Clinical Oncology, Cancer, Ageing, Quality of life, Medicine, Oncology, GA, Comprehensive geriatric assessment, Immunotherapy, Bangladesh Technical Education Board, Science, ASCO, Boil, National Cancer Institute, Journal, Patient, Guideline, Physician, Area studies, Education minister, LOS, Research, Food, Environment, Society, Nursing, Dietary supplement, City

LOS ANGELES, July 17, 2023 /PRNewswire/ -- In an effort to improve treatment outcomes and quality of life for older adults with cancer, researchers from City of Hope, one of the largest cancer research and treatment organizations in the United States, and colleagues across the country today released updated guidelines by the American Society of Clinical Oncology (ASCO) outlining the need to assess and manage vulnerabilities in patients aged 65 and older prior to prescribing chemotherapy, targeted therapy and/or immunotherapy.

Key Points: 
  • "Studies continue to prove that patients and families win when care teams ask older adults with cancer the right questions at the outset.
  • An alarming 60% of oncologists said they did not use a formal GA for any of their older adult patients.
  • (Advanced age is the most important risk factor for cancer: Half of people first diagnosed with cancer are over 66 years old, according to National Cancer Institute data .)
  • The updated ASCO cancer and aging recommendations detail an expert panel's review of 26 studies from randomized clinical trials, cohort studies and systematic reviews.

Oncology Precision Medicine Market Report 2022: Gene Therapy Represents Lucrative Growth Opportunities - ResearchAndMarkets.com

Retrieved on: 
Tuesday, November 29, 2022
Research, Genetics, Clinical Trials, Stem Cells, Radiology, General Health, Pharmaceutical, Health, Science, Oncology, Growth, Precision medicine, Diagnosis, Organization, Prevalence, Comprehensive geriatric assessment, Conditional sentence, Ecosystem, Cancer, Fetus, Patient, Oncology, Chromosome, Disease, NGS, Application, Investment, Health status of Asian Americans, Medical imaging

The global oncology precision medicine market is expected to grow at an impressive CAGR in the forecast period, 2023-2027.

Key Points: 
  • The global oncology precision medicine market is expected to grow at an impressive CAGR in the forecast period, 2023-2027.
  • Gene therapy considered as one of the most lucrative markets for precision medicine organizations.
  • Genome sequencing is an unavoidable stage of gene therapy, the extensive investments that are being made in this field drives the growth of the precision medicine market.
  • In this report, global oncology precision medicine market has been segmented into following categories, in addition to the industry trends which have also been detailed below:

Less Chemotherapy, Fewer Falls, Personalized Care: Study Reinforces Major Strides in Geriatric Oncology

Retrieved on: 
Thursday, November 4, 2021
Family, Society, Falls, University, Cancer, Health, University of Rochester Medical Center, Comprehensive geriatric assessment, Research, American Society of Clinical Oncology, Philip, ASCO, GA, Collection, Communication, Diabetes, Survival, Patient, Social support, URMC, Ageing, Medical imaging

But the new study proves that more personalized care can be delivered safely to older adults, based on their medical histories and individual circumstances.

Key Points: 
  • But the new study proves that more personalized care can be delivered safely to older adults, based on their medical histories and individual circumstances.
  • The randomized clinical trial involved 718 patients with a mean age of 72, who had advanced cancer and other aging-related conditions.
  • The Lancet data adds to a growing collection of geriatric oncology research addressing the most effective ways to treat the oldest people facing cancer.
  • The study noted that 60 percent of all cancers and 70 percent of all cancer deaths occur in older adults elevating the importance of geriatric oncology research.

Older Adults Who Receive Additional Supportive Care Services Experience Fewer Side Effects From Chemotherapy, City of Hope Study Finds

Retrieved on: 
Thursday, September 30, 2021
Biotechnology, Managed Care, Health, Radiology, Seniors, Pharmaceutical, Oncology, Research, Consumer, Science, Clinical Trials, Goal, Clinical trial, Oncology, U.S. News & World Report, Biomedical Research, Weight loss, Research, Instagram, Standard of care, National Cancer Institute, NIA, City of Hope, Overalls, News, National, Patient, JAMA Oncology, Precision medicine, National Comprehensive Cancer Network, YouTube, Comprehensive geriatric assessment, GAIN, Immunotherapy, Diabetes, Twitter, Haematopoietic system, Center, Mental health, Translational Genomics Research Institute, Technology, CAR, Arm, Maintenance, Survival, NCI, Manuscript, Quality of life, Pharmaceutical industry, Medicine, Dietary supplement

A multidisciplinary group of experts reviewed the geriatric assessments and recommended extra services to address the experimental groups vulnerable areas.

Key Points: 
  • A multidisciplinary group of experts reviewed the geriatric assessments and recommended extra services to address the experimental groups vulnerable areas.
  • Older adults know what they want from their lives and prioritize the ability to continue to do the things they enjoy doing.
  • In other words, the ability to tolerate treatment and not be miserable is equally as important, if not more important, than survival to older adults.
  • AccessHope TM, a subsidiary launched in 2019, serves employers and their health care partners by providing access to NCI-designated cancer center expertise.